The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds & GE Ventures Form Strategic Alliance

29 Sep 2016 07:00

RNS Number : 1349L
Allied Minds PLC
29 September 2016
 

 

29 SEPTEMBER 2016

Allied Minds plc

Allied Minds and GE Ventures Form Strategic Alliance

 

Boston, Mass. -- September 29, 2016 - As announced earlier today, Allied Minds plc (LSE: ALM) launched a strategic alliance with GE Ventures (NYSE: GE) to jointly identify and commercialise next-generation technologies. Under the terms of the agreement, Allied Minds and GE Ventures agree to invest in new and existing technologies sourced from both Allied Minds and GE's innovation pipelines.

 

The strategic alliance expands Allied Minds' deep network of research and development partners to include GE's leading early stage technologies in healthcare, transportation, energy, and big data. Allied Minds receives an exclusive right of first refusal to license certain technologies, chosen by GE, which are of strategic interest to the companies.

 

GE will have the opportunity to invest in select innovations sourced from Allied Minds' network of over 160 university and federal research partners. As part of the alliance, GE also receives an option to participate in any future capital raise by Allied Minds plc for at least 6% of the total raise, subject to current pre-emption rights, applicable authorisations and applicable law and regulations.

 

Each year, Allied Minds reviews thousands of intellectual property ("IP") opportunities from some of the nation's best universities and federal labs to identify innovations with the potential to have a significant impact on commercial markets. If an emerging technology passes its due diligence, Allied Minds forms, funds, manages, and builds a subsidiary company that gives the inventors and their institutions a stake in its success. 

 

GE Ventures accelerates innovation and growth for its partners by providing access to GE's cutting-edge technologies and an extensive IP portfolio through licensing, technology transfer, joint development, and other strategic business models. By bringing together Allied Minds' commercialisation process and GE Ventures' innovation expertise, the strategic alliance can leverage the combined technology, marketing, fundraising, start-up development, and management capabilities of the two entities.

 

- Ends-

For more information, please contact:

Allied Minds plc

 

Chris Silva, Chief Executive Officer

+1 617 419 1800

 

www.alliedminds.com

Citigate Dewe Rogerson

 

Patrick Donovan/Rob Newman

+44 20 7638 9571

 

alliedminds@citigatedr.co.uk

 

Notes to Editors

About Allied Minds

 

Allied Minds (LSE: ALM) is a diversified holding company focused on venture creation within the life science and technology sectors. With unparalleled access to hundreds of university and federal labs across the U.S., Allied Minds forms, funds, and operates a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, with nationwide presence in Los Angeles and New York, Allied Minds supports its businesses with capital, central management, and shared services. For more information, please visit www.alliedminds.com.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKFDDABKDACB
Date   Source Headline
29th Nov 20224:40 pmRNSSecond Price Monitoring Extn
29th Nov 20224:35 pmRNSPrice Monitoring Extension
28th Nov 202210:15 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
28th Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in own shares
25th Nov 20225:30 pmRNSAllied Minds
25th Nov 20223:20 pmRNSForm 8.3 - Allied Minds PLC
25th Nov 20229:03 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
25th Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in own shares
24th Nov 202210:42 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
24th Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in own shares
23rd Nov 20229:07 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
23rd Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in own shares
22nd Nov 20223:17 pmRNSForm 8.3 - Allied Minds PLC
22nd Nov 20229:29 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
22nd Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in own shares
21st Nov 20229:31 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
21st Nov 20227:00 amRNSRule 2.9 Announcement - Transaction in Own Shares
18th Nov 20223:25 pmRNSRule 2.9 Announcement
18th Nov 20229:43 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 202211:16 amRNSShare Buyback Programme
8th Nov 20223:30 pmRNSForm 8.3 - Allied Minds PLC
4th Nov 20223:24 pmRNSForm 8.3 - Allied Minds PLC
3rd Nov 20223:09 pmRNSForm 8.3 - Allied Minds PLC
2nd Nov 20227:00 amRNSResult of General Meeting
1st Nov 202210:01 amRNSForm 8 (DD) - Allied Minds PLC
1st Nov 20229:49 amRNSForm 8 (DD) - ALLIED MINDS PLC
1st Nov 20229:46 amRNSForm 8 (DD) - Allied Minds PLC
1st Nov 20229:45 amRNSForm 8 (DD) - Allied Minds PLC
1st Nov 20229:45 amRNSForm 8 (DD) - Allied Minds PLC
31st Oct 20223:59 pmRNSDirector/PDMR Shareholding
31st Oct 202211:06 amRNSForm 8.3 - Allied Minds plc
31st Oct 202211:02 amRNSForm 8.3 - Allied Minds plc
31st Oct 202210:54 amRNSForm 8.3 - Allied Mines plc
31st Oct 202210:17 amRNSForm 8.3 - Allied Minds plc
31st Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Oct 20225:15 pmRNSDirectorate Change
14th Oct 20223:44 pmRNSPDMR Notification
13th Oct 20225:30 pmRNSForm 8.3 - Allied Minds Plc
13th Oct 20225:29 pmRNSForm 8.3 - Allied Minds Plc
13th Oct 20225:28 pmRNSForm 8.3 - Allied Minds Plc
7th Oct 20224:10 pmRNSPosting of Circular; Change to Board of Directors
30th Sep 20224:36 pmRNSPrice Monitoring Extension
30th Sep 20229:26 amRNSForm 8.5 (EPT/RI) - Allied Minds PLC
30th Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSTrading Update
30th Aug 20225:43 pmRNSHolding(s) in Company
26th Aug 20224:41 pmRNSSecond Price Monitoring Extn
26th Aug 20224:36 pmRNSPrice Monitoring Extension
26th Aug 20224:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.